Investor-aversion led to growth adventure for Gubra
BY ELIZABETH MØNSTED JOHANSEN
Bad experiences made the founders of Gubra eager to keep investors out of the company. It slowed down the company’s development but at the same time, it made Gubra play a significant role in preclinical research and the Danish life science industry.
Log in to read our articles
Welcome to MedWatch. A part of our content is exclusive and reserved for our users.